Cargando…
High-dose antioxidants for central serous chorioretinopathy; The randomized placebo-controlled study
BACKGROUND: To determine the efficacy of high-dose antioxidants in the acute stage of central serous chorioretinopathy (CSC). METHODS: This was a randomized placebo-controlled study. The patients with acute CSC (onset within 6 weeks) were randomized to receive either high-dose antioxidant tablets (s...
Autores principales: | Ratanasukon, Mansing, Bhurayanontachai, Patama, Jirarattanasopa, Pichai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3410804/ https://www.ncbi.nlm.nih.gov/pubmed/22800086 http://dx.doi.org/10.1186/1471-2415-12-20 |
Ejemplares similares
-
Photoreceptor disruption in central serous chorioretinopathy treated by half-dose photodynamic therapy
por: Ratanasukon, Mansing, et al.
Publicado: (2013) -
One-year results of half-dose versus one-third-dose photodynamic therapy in chronic or recurrent central serous chorioretinopathy
por: Pichai, Jirarattanasopa, et al.
Publicado: (2021) -
Electrophysiologic changes after intravitreal ranibizumab injection for the treatment of choroidal neovascular membrane (CNVM)
por: Bhurayanontachai, Patama, et al.
Publicado: (2011) -
Polypoidal choroidal vasculopathy (PCV): the 4-year review of the real-life treatment experiences
por: Ratanasukon, Mansing, et al.
Publicado: (2018) -
The Impact of Vision Impairment (IVI) Questionnaire; Validation of the Thai-Version and the Implementation on Vision-Related Quality of Life in Thai Rural Community
por: Ratanasukon, Mansing, et al.
Publicado: (2016)